Punica granatum

Pomella® Pomegranate Extract

What is Pomella® Pomegranate Extract?

Patented Pomella® pomegranate extract delivers an ellagitannin rich profile standardized to punicalagin content and gut-derived metabolites to hone in on an array of antioxidant related health benefits. The antioxidant benefits of Pomella’s powerful polyphenols help support tangible health applications and contribute to overall wellbeing.

Key Attributes:

Punica granatum extract

Global intellectual property & multiple patents

Standardized to punicalagins

150 – 300mg / day

Clinically researched for a multitude of tangible health applications

Punica granatum

Pomella® Pomegranate Extract

Punica granatum

Pomella® Pomegranate Extract

What is Pomella® Pomegranate Extract?

Patented Pomella® pomegranate extract delivers an ellagitannin rich profile standardized to punicalagin content and gut-derived metabolites to hone in on an array of antioxidant related health benefits. The antioxidant benefits of Pomella’s powerful polyphenols help support tangible health applications and contribute to overall wellbeing.

Key Attributes:

  • Punica granatum extract
  • 150 – 300mg / day
  • Global intellectual property & multiple patents
  • Clinically researched for a multitude of tangible health applications
  • Standardized to punicalagins

Use Pomella® With Confidence In Your Formulations

From concept to commercialization, we are able to use our new in-house Insights Lab to provide new solutions with masking, taste profile, texture, and other formulation issues often associated with botanicals in various delivery formats.

verdure-sciences-insights-lab-logo-full-color-1000x626

Use Pomella® With Confidence In Your Formulations

From concept to commercialization, we are able to use our new in-house Insights Lab to provide new solutions with masking, taste profile, texture, and other formulation issues often associated with botanicals in various delivery formats.

verdure-sciences-insights-lab-logo-full-color-1000x626
verdure-sciences-insights-lab-logo-full-color-1000x626

Use Pomella® With Confidence In Your Formulations

From concept to commercialization, we are able to use our new in-house Insights Lab to provide new solutions with masking, taste profile, texture, and other formulation issues often associated with botanicals in various delivery formats.

The Next Frontier in Pet Health: Emerging Trends for Formulators
May 14, 2024
Pet ownership is at an all-time high, with 66% of US households owning at least one pet. From this, it’s no surprise that the global pet care market is estimated to grow from $246 billion in 2023 to $368 billion by 2030.
Breaking Boundaries: Insights Shaping Women’s Health
March 13, 2024
In the dynamic landscape of health and wellness, women’s health has been considered a niche market, despite women accounting for 80% of consumer purchasing decisions.
New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health
January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.
New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities
October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.
The Next Frontier in Pet Health: Emerging Trends for Formulators
May 14, 2024
Pet ownership is at an all-time high, with 66% of US households owning at least one pet. From this, it’s no surprise that the global pet care market is estimated to grow from $246 billion in 2023 to $368 billion by 2030.
Breaking Boundaries: Insights Shaping Women’s Health
March 13, 2024
In the dynamic landscape of health and wellness, women’s health has been considered a niche market, despite women accounting for 80% of consumer purchasing decisions.
New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health
January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.
New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities
October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.
The Next Frontier in Pet Health: Emerging Trends for Formulators
May 14, 2024
Pet ownership is at an all-time high, with 66% of US households owning at least one pet. From this, it’s no surprise that the global pet care market is estimated to grow from $246 billion in 2023 to $368 billion by 2030.
Breaking Boundaries: Insights Shaping Women’s Health
March 13, 2024
In the dynamic landscape of health and wellness, women’s health has been considered a niche market, despite women accounting for 80% of consumer purchasing decisions.
New Research: Pomella® May Support Gut Microbiome, Short Chain Fatty Acids, And Impact Mitochondrial Health
January 2, 2024
A new four-week, double-blind, placebo-controlled, randomized clinical trial evaluated 250mg/day Pomella®, a proprietary Punica granatum extract, in healthy men and women 25-55yrs (n=18, predominantly women) for beneficial effects on the gut microbiome, circulating short-chain fatty acids, and gut-microbial derived ellagitannin metabolites, namely urolithins, using whole genome sequencing for gut microbial analysis.
New Research: Pomella® Pomegranate Extract Ellagitannins Further Proven To Convert To Urolithins; Polyphenol Capabilities
October 6, 2023
A new study with Pomella®, a proprietary Punica granatum extract, has evaluated bioavailability and absorption properties adding understanding to Pomella’s synergistic influence and polyphenol capabilities.